J. A. S. Cavaleiro et al.
FULL PAPER
were dissolved in 2 mL of a stock solution of the catalyst [0.1 µmol
4-Cholesten-3-ol (2c): tR ϭ 3.96 min (dehydration occurs in the in-
of catalyst per mL of CH2Cl2/CH3CN (1:1)] and stirred at room jector). MS (EI): m/z (%) ϭ 368 (100) [Mϩ· Ϫ 18], 353 (50). 1H
temperature. Aqueous hydrogen peroxide (30% w/w) diluted with
acetonitrile (1:20) was added to the reaction mixture in 30 µL ali-
quots every 15 min.
NMR (300.13 MHz): δ ϭ 0.68 (s, 3 H, 18-H), 0.862 and 0.865 (2
d, J ϭ 6.6 Hz, 3 ϫ 2 H, 26-H and 27-H), 0.90 (d, J ϭ 6.1 Hz, 3
H, 21-H), 1.00 (s, 3 H, 19-H), 4.05Ϫ4.11 (m, 1 H, 3-H), 5.46 (dd,
J ϭ 1.5, 4.8 Hz, 1 H, 4-H) ppm. 13C NMR (75.47 MHz): δ ϭ 64.3
(C-3), 120.6 (C-4), 150.5 (C-5) ppm.
Oxidation Reactions with FeIII Porphyrins: In a typical experiment,
the substrate (0.03 mmol) was dissolved in 2 mL of a stock solution
of the catalyst [0.1 µmol of catalyst per mL of CH3OH/CH2Cl2
(3:1)] and stirred at room temperature. Aqueous hydrogen peroxide
(30% w/w) diluted with acetonitrile (1:20) was added to the reaction
mixture in 30 µL aliquots every 15 min.
4-Cholesten-3-one (2d): tR ϭ 6.35 min. MS (EI): m/z (%) ϭ 384 (40)
1
[Mϩ·], 342 (20). H NMR (300.13 MHz): δ ϭ 0.67 (s, 3 H, 18-H),
0.86 (d, J ϭ 6.6 Hz, 6 H, 26-H and 27-H), 0.91 (d, J ϭ 6.4 Hz, 3
H, 21-H), 1.05 (s, 3 H, 19-H), 5.72 (s-broad, 1 H, 4-H) ppm. 13C
NMR (75.47 MHz): δ ϭ 123.7 (C-4), 171.8 (C-5), 119.7 (C-3) ppm.
Reaction Control: Aliquots were withdrawn from the reaction mix-
ture and injected directly into the GC injector. The addition of
H2O2 was stopped when the relative proportion of the compounds
remained constant after two successive GC analyses. Reaction con-
versions and product yields were based on the 1H NMR spectra of
the reaction mixture. This type of approach was possible because
the various components of the reaction mixture exhibit distinct sig-
nals between δ ϭ 2 and 6 ppm. Only the H-4 signals of the two
isomers of 4,5-epoxides (Scheme 1) are not distinguishable in that
region of the 1H NMR spectra; their relative abundance was deter-
3-Hydroxy-4,5-epoxycholestane (2e): tR ϭ 6.30 min (dehydration
occurs in the injector). MS (EI): m/z (%) ϭ 384 (10) [Mϩ· Ϫ 18].
1H NMR (500.13 MHz): δ ϭ 0.68 (s, 3 H, 18-H), 0.868 and 0.872
(2 d, J ϭ 6.6 Hz, 2 ϫ 3 H, 26-H and 27-H), 0.91 (d, J ϭ 6.5 Hz,
3 H, 21-H), 1.00 (s, 3 H, 19-H), 1.03Ϫ1.09 (m, 1 H, 6-H),
1.05Ϫ1.07 (m, 1 H, 22-H), 1.05Ϫ1.12 (2m, 2 ϫ 1 H, 14-H and 17-
H), 1.08Ϫ1.18 (2m, 1H ϩ2 H, 12-H and 24-H), 1.14Ϫ1.18 (m, 1
H, 1-H), 1.28Ϫ1.32 (2m, 2 ϫ 1 H, 2-H and 9-H), 1.34Ϫ1.40 (2m,
2 ϫ 1 H, 20-H and 22-H), 1.36Ϫ1.40 (m, 1 H, 1-H), 1.41Ϫ1.46 (2m,
1H ϩ2 H, 8-H and 11-H), 1.70Ϫ1.73 (m, 1 H, 2-H), 1.74Ϫ1.79 (m,
2 H, 7-H), 2.00 (dt, J ϭ 3.3, 12.8 Hz, 1 H, 12-H), 2.03Ϫ2.13 (m, 1
H, 6-H), 2.85 (s, 1 H, 4-H), 3.97 (t, J ϭ 8.4 Hz, 1 H, 3-H) ppm.
13C NMR (125.76 MHz): δ ϭ 11.9 (C-18), 18.6 (C-21), 18.7 (C-19),
21.1 (C-11), 22.5 and 22.8 (C-26,27), 23.8 and 24.2 (C-15,16), 25.7
(C-2), 26.0 (C-1), 28.0 (C-25), 28.2 (C-23), 30.2 (C-7), 30.9 (C-6),
35.0 (C-8), 35.7 (C-20), 36.1 (C-22), 36.3 (C-10), 39.4 (C-24), 39.7
(C-12), 42.5 (C-13), 46.0 (C-9), 56.0 and 56.2 (C-14,17), 65.8 (C-
4), 66.8 (C-5,3) ppm.
1
mined by the intensity of the H NMR singlets of H-19 (δ ϭ 1.07
ppm for the α-epoxide and δ ϭ 1.01 ppm for the β-epoxide).
Isolation and Characterization of Reaction Products: The reaction
mixture components were separated by preparative thin-layer chro-
matography on silica gel. Oxidation products from 1 were eluted
with a mixture of CH2Cl2/light petroleum (4:1), whereas the oxi-
dation products from 2 were eluted with a mixture of CH2Cl2/light
petroleum (1:1). Crystals of epoxides 1a and 1b, suitable for X-ray
diffraction, were obtained by recrystallization from a mixture of
dichloromethane and methanol. Compounds 3a and 3b were iso-
lated by column chromatography on silica gel eluting with a (7:3)
mixture of CH2Cl2 and light petroleum.
3-β-Acetoxy-5,6-β-epoxycholestane (3a): tR ϭ 7.46 min (loss of
acetic acid occurs in the injector). MS (EI): m/z (%) ϭ 384 (14)
1
[Mϩ Ϫ 60], 356 (8). H NMR (300.13 MHz): δ ϭ 0.64 (s, 3 H, 18-
H), 0.858 and 0.861 (2 d, J ϭ 6.7 Hz, 2 ϫ 3 H, 26-H and 27-H),
0.89 (d, J ϭ 7.7 Hz, 3 H, 21-H), 1.00 (s, 3 H, 19-H), 2.03 (s, 3 H,
3-OAc), 3.08 (d, J ϭ 1.6 Hz, 1 H, 6-H), 4.71Ϫ4.82 (m, 1-H, 3-
H) ppm.
17β-Acetoxy-4,5β-epoxyandrostane (1a): Retention time (tR):
2.64 min. MS (EI): m/z (%) ϭ 332 (15) [Mϩ·], 304 (6). M.p.
156.4Ϫ157.6 °C. NMR spectroscopic data are given in Table 2.
3-β-Acetoxy-5,6-α-epoxycholestane (3b): tR ϭ 8.20 min (loss of
acetic acid occurs in the injector). MS (EI): m/z (%) ϭ 384 (13)
17β-Acetoxy-4,5α-epoxyandrostane (1b): tR ϭ 2.74 min. MS (EI):
m/z (%) ϭ 332 (26) [Mϩ·], 304 (15). M.p. 137.6Ϫ139.4 °C. NMR
spectroscopic data are given in Table 2.
1
[Mϩ· Ϫ 60], 366 (9). H NMR (300.13 MHz): δ ϭ 0.61 (s, 3 H, 18-
H), 0.860 and 0.861 (2 d, J ϭ 6.7 Hz, 2 ϫ 3 H, 26-H and 27-H),
0.89 (d, J ϭ 7.7 Hz, 3 H, 21-H), 1.07 (s, 3 H, 19-H), 2.02 (s, 3 H,
3-OAc), 2.90 (d, J ϭ 4.3 Hz, 1 H, 6-H), 4.89Ϫ5.00 (m, 1-H, 3-
H) ppm.
17β-Acetoxy-4-androsten-3-ol (1c): tR ϭ 2.45 min (dehydration oc-
curs in the injector). MS (EI): m/z (%) ϭ 314 (25) [Mϩ· Ϫ 18], 299
(5). H NMR (300.13 MHz): δ ϭ 0.81 (s, 3 H, 18-H), 0.99 (s, 3 H,
19-H), 2.04 (s, 3 H, 21-H), 4.04Ϫ4.09 (m, 1 H, 3-H), 4.58 (dd, J ϭ
7.9, 9.0 Hz, 1 H, 17-H), 5.47 (dd, J ϭ 1.6, 5.0 Hz, 1 H, 4-H) ppm.
1
Acknowledgments
Thanks are due to Fundac¸a˜o para a Ciencia e a Tecnologia (FCT)
for funding the Project 39593/Qui/2001 and also the Aveiro Organic
Chemistry Research Group. S. L. H. R. also thanks FCT for a
PhD grant.
17β-Acetoxy-4-androsten-3-one (1d): tR ϭ 3.57 min. MS (EI): m/z
ˆ
1
(%) ϭ 330 (10) [Mϩ·], 288 (15). H NMR (300.13 MHz): δ ϭ 0.84
(s, 3 H, 18-H), 0.99 (s, 3 H, 19-H), 2.05 (s, 3 H, 21-H), 4.58 (dd,
J ϭ 7.9, 9.0 Hz, 1 H, 17-H), 5.74 (d, J ϭ 1.1 Hz, 1 H, 4-H) ppm.
17β-Acetoxy-3-hydroxy-4,5-epoxyandrostane (1e): tR ϭ 3.45 min
(dehydration occurs in the injector). MS (EI): m/z (%) ϭ 330 (15)
[1]
P. M. Dewick, in Medicinal Natural Products, a Biosynthetic
1
[Mϩ· Ϫ 18]. H NMR (300.13 MHz): δ ϭ 0.81 (s, 3 H, 18-H), 1.01
Approach, John Wiley & Sons, Chichester, 1997.
[2]
(s, 3 H, 19-H), 2.05 (s, 3 H, 21-H), 2.85 (s, 1 H, 4-H), 3.98 (t, J ϭ
5.6 Hz, 1 H, 3-H), 4.60 (t, J ϭ 8.4 Hz, 1 H, 17-H) ppm.
A. M. H. Brodie, V. C. O. Njar, Steroids 2000, 65, 171.
[3]
J. Mc Lain, J. Lee, J. T. Groves, in Biomimetic Oxidations Cata-
lysed by Transition Metal Complexes (Ed.: B. Meunier), Im-
perial College Press, London, 2000, p. 127.
4,5β-Epoxycholestane (2a): tR ϭ 4.47 min. MS (EI): m/z (%) ϭ 386
[4]
(100) [Mϩ·], 358 (35). NMR spectroscopic data are given in Table 4.
M. Numazawa, K. Yamada, Steroids 1999, 64, 320.
[5]
´
Z. Freixa, M. M. Pereira, J. C. Bayon, A. M. S. Silva, J. A. R.
4,5α-Epoxycholestane (2b): tR ϭ 4.84 min. MS (EI): m/z (%) ϭ 386
Salvador, A. M. Beja, J. A. Paixa˜o, M. Ramos, Tetrahedron:
Asymmetry 2001, 12, 1083.
(100) [Mϩ·], 358 (35). NMR spectroscopic data are given in Table 4.
4786
© 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2004, 4778Ϫ4787